Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Leicester researchers discover a potential molecular defence against Huntington's disease

University of Leicester experts discover glutathione peroxidase activity improves symptoms in models of the neurodegenerative disorder

Leicester geneticists have discovered a potential defence against Huntington's disease – a fatal neurodegenerative disorder which currently has no cure.

The team of University of Leicester researchers identified that glutathione peroxidase activity – a key antioxidant in cells – protects against symptoms of the disease in model organisms.

They hope that the enzyme activity – whose protective ability was initially observed in model organisms such as yeast - can be further developed and eventually used to treat people with the genetically-inherited disease.

The disease affects around 12 people per 100,000.

Their paper, Glutathione peroxidase activity is neuroprotective in models of Huntington's disease, was published in Nature Genetics on 25 August.

A team of experts from the University's Department of Genetics carried out research for more than six years to identify new potential drug targets for the disease.

They used model systems, such as baker's yeast, fruit flies, and cultured mammalian cells to help uncover potential mechanisms underlying disease at the cellular level.

They initially screened a genome-wide collection of yeast genes and found several candidates which protected against Huntington's related symptoms in yeast. They then validated their findings in fruit flies and mammalian cells.

They found that glutathione peroxidase activity is robustly protective in these models of Huntington's disease.

Importantly, there are drug-like compounds available that mimic this activity that have already been tested in human clinical trials for other disorders – which potentially means the approach could be used to treat people with the disease.

The team now aim to further validate the observations regarding glutathione peroxidase activity, in order to understand whether this could have therapeutic relevance for Huntington's.

In addition, they have identified many additional genes that are protective - and aim to further explore these to see if there are any additional therapeutic possibilities suggested by their research.

Dr Flaviano Giorgini, Reader in Neurogenetics of the University's Department of Genetics and senior author of the paper, said: "We are taking advantage of genetic approaches in simple model organisms in order to better understand Huntington's disease, with the aim of uncovering novel ways to treat this devastating disorder.

"It appears that glutathione peroxidase activity is a robustly protective antioxidant approach which may have relevance for Huntington's disease."

Dr Robert Mason, Research Associate in the Department of Genetics, and first author of the study, said: "In addition to glutathione peroxidase, this study has identified many genes that improve Huntington's 'symptoms' in yeast. These genes provide valuable information on the underlying mechanisms leading to Huntington's, and further study will likely uncover additional approaches that could be beneficial in treating this terrible disease."

Dr Giorgini stated: "We are excited by the work because it uncovers a potential new route for therapeutics in Huntington's disease. I am also proud that all of this work has been conducted at the Department of Genetics at the University of Leicester."

The study was performed in collaboration with Prof Charalambos Kyriacou, also of the Department of Genetics at Leicester. Massimiliano Casu, Nicola Butler, Dr Carlo Breda, Dr Susanna Campesan, Dr Jannine Clapp, Dr Edward Green and Devyani Dhulkhed also contributed to the research study.

The research was primarily funded by CHDI Foundation and the Huntington's Disease Association.

Dr. Flaviano Giorgini | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>